induced changes in the expression of immune-related genes in the liver but did not produce prominent changes in neuroimmune pathways in C57BL/6J mice (Ferguson et al., 2014). NF-κB targets were not downregulated in liver or brain following PPAR agonist treatment, but it should be noted that these mice were ethanol naive (Ferguson et al., 2014).
